Status:
RECRUITING
Evaluation of Technological Innovation in Radiotherapy
Lead Sponsor:
Centre hospitalier de l'Université de Montréal (CHUM)
Conditions:
Cancer
Radiotherapy Side Effect
Eligibility:
All Genders
18+ years
Brief Summary
Prospective cohort study of patients receiving standard-care radiotherapy is paramount to a better understanding of radiation effects and longterm outcomes. The primary objective is to determine the ...
Detailed Description
The study consists of an effort to develop infrastructure that will support systematic collection of data from daily radiotherapy practice. At the core, PERA is a large observational cohort study, ser...
Eligibility Criteria
Inclusion
- Ability to provide informed consent
- Receiving radiotherapy or brachytherapy
Exclusion
- \-
Key Trial Info
Start Date :
November 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2025
Estimated Enrollment :
1500 Patients enrolled
Trial Details
Trial ID
NCT03378856
Start Date
November 1 2017
End Date
October 1 2025
Last Update
December 20 2024
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
London Health Regional Cancer Centre
London, Ontario, Canada
2
Princess Margaret Cancer Centre
Toronto, Ontario, Canada
3
Centre de santé et de services sociaux de Laval
Laval, Quebec, Canada
4
Centre Hospitalier de l'Université de Montréal
Montreal, Quebec, Canada